Sudden cardiac death in adult with prior history of Kawasaki disease without coronary artery involvement: A case report Lisa Connelly was 37 when she passed away from a massive heart attack on November 29, 2015. The pathology report showed...
Read More
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial Summary Background Although intravenous immunoglobulin (IVIG) is effective therapy for Kawasaki disease, 10–20% of patients have recrudescent fever...
Same Treatment Tested for Kids with Kawasaki Disease and Rare COVID-19 Reaction In a pair of new studies, published online October 26 and August 31, 2021, two collaborating teams of researchers at University of California San Diego School of...
What: UCSD 2021 Virtual Kawasaki Disease Parent Symposium When: Saturday, October 2, 2021, from 9 am to 12 pm PST Who: Jane C. Burns, M.D. Director, UCSD KD Research Center | Adriana Tremoulet, M.D. Associate Director, UCSD KD Research...
What: UCSD 2021 Virtual Kawasaki Disease Parent Symposium When: Saturday, October 2, 2021, from 9 am to 12 pm PST Who: Jane C. Burns, M.D. Director, UCSD KD Research Center | Adriana Tremoulet, M.D. Associate Director, UCSD KD Research...
Researcher: Kawasaki Disease Spike In San Diego Likely Tied To Aerosol Particles An unusual and potentially deadly disease is making a growing number of San Diego County children sick, and researchers say it’s caused by something in the air....
Fever, conjunctivitis, rash, and belly pain KD case study written by two medical doctors highlights that children with KD and prominent GI (gastrointestinal (GI) symptoms of abdominal pain and diarrhea) or hepatobiliary (having to do with the liver plus...
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis Coronary artery aneurysms (CAA) are a serious complication of Kawasaki disease. Treatment with intravenous immunoglobulin (IVIg) within 10 days of fever onset reduces the risk of CAA...
Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial Dr. Michael A. Portman and colleagues have published the results of a clinical trial showing benefits by etanercept (brand name Enbrel) for Kawasaki Disease patients. The results were...
Groundbreaking research at Seattle Children’s Hospital to help diagnose rare health condition SEATTLE – A groundbreaking researching happening right here in Washington is giving doctors new hope at better treating and diagnosing a rare health condition called Kawasaki disease....